Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 61 AL 75

US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development

Morant AV, Vestergaard HT, Lassen AB, Navikas V.

Clin Transl Sci. 2020 Jul;13(4):652-664. doi: 10.1111/cts.12755. Epub 2020 Mar 3.

Alzheimer's disease: targeting the glutamatergic system

Conway ME.

Biogerontology. 2020 Jun;21(3):257-274. doi: 10.1007/s10522-020-09860-4. Epub 2020 Feb 11.

Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer's Disease

Caffino L, Mottarlini F, Fumagalli F.

CNS Drugs. 2020 Mar;34(3):281-297. doi: 10.1007/s40263-020-00705-9.

Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial

Shi J, Wei M, Ni J, Sun F, Sun L, Wang J, Yu T, Wang K, Lv P, Wang Y, Zhang Y, Gao X, Gao X, Luo B, Mao S, Zhang B, Ren X, Yu F, Hu W, Yin P, Wu N, Liu X, Bi Q, Wang Y, Tian J; CHASE Study Group.

J Transl Med. 2020 Feb 13;18(1):76. doi: 10.1186/s12967-020-02232-z.

Scopolamine, a Toxin-Induced Experimental Model, Used for Research in Alzheimer's Disease

Chen WN, Yeong KY.

CNS Neurol Disord Drug Targets. 2020;19(2):85-93. doi: 10.2174/1871527319666200214104331.

Acute cholinergic syndrome in a patient taking the prescribed dose of donepezil for Alzheimer's disease

Hanazawa T, Kamijo Y, Yoshizawa T, Fujita Y, Usui K, Haga Y.

Psychogeriatrics. 2020 Jul;20(4):538-539. doi: 10.1111/psyg.12531. Epub 2020 Feb 17.

Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges

López ES, Machado ALL, Vidal LB, González-Pizarro R, Silva AD, Souto EB.

Curr Pharm Des. 2020;26(12):1235-1250. doi: 10.2174/1381612826666200218101231.

Disease Modification in Alzheimer's Disease: Current Thinking

Liu-Seifert H, Schumi J, Miao X, Tian Y, Rabbia M, Andersen SW, Wilson S, Li W, Entsuah R.

Ther Innov Regul Sci. 2020 Mar;54(2):396-403. doi: 10.1007/s43441-019-00068-4. Epub 2020 Jan 6.

Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer's Disease: A Re-Analysis of the CATIE-AD Study

Nagata T, Shinagawa S, Yoshida K, Noda Y, Shigeta M, Mimura M, Nakajima S.

J Clin Psychiatry. 2020 Feb 11;81(2):19m12961. doi: 10.4088/JCP.19m12961.

Human-Induced Pluripotent Stem Cells and Herbal Small-Molecule Drugs for Treatment of Alzheimer's Disease

Wuli W, Tsai ST, Chiou TW, Harn HJ.

Int J Mol Sci. 2020 Feb 16;21(4):1327. doi: 10.3390/ijms21041327.

LW-AFC, a new formula from the traditional Chinese medicine Liuwei Dihuang decoction, as a promising therapy for Alzheimer's disease: Pharmacological effects and mechanisms

Cheng X, Huang Y, Zhang Y, Zhou W.

Adv Pharmacol. 2020;87:159-177. doi: 10.1016/bs.apha.2019.10.005. Epub 2020 Jan 3.

Lemborexant: First Approval

Scott LJ.

Drugs. 2020 Mar;80(4):425-432. doi: 10.1007/s40265-020-01276-1.

Targeting Post-Translational Remodeling of Ryanodine Receptor: A New Track for Alzheimer's Disease Therapy?

Chami M, Checler F.

Curr Alzheimer Res. 2020;17(4):313-323. doi: 10.2174/1567205017666200225102941.

Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands

Iraji A, Khoshneviszadeh M, Firuzi O, Khoshneviszadeh M, Edraki N.

Bioorg Chem. 2020 Apr;97:103649. doi: 10.1016/j.bioorg.2020.103649. Epub 2020 Feb 4.

Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques

Zhu X , Victor TW , Ambi A , Sullivan JK , Hatfield J , Xu F , Miller LM , Van Nostrand WE .

Metallomics. 2020 Apr 1;12(4):539-546. doi: 10.1039/c9mt00306a. Epub 2020 Feb 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias